From July 1, 2022 to December 31, 2022, the company has repurchased 2,335,000 shares, representing 0.41% for HKD 8 million. With this, the company has completed the repurchase of 3,132,000 shares, representing 0.55% for HKD 10.9 million under the buyback announced on May 12, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.39 HKD | +0.42% | +9.13% | -4.02% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-4.02% | 173M | |
-3.79% | 87.06B | |
+1.45% | 40.25B | |
-16.16% | 31.09B | |
+52.66% | 24.74B | |
-14.28% | 15.91B | |
-9.12% | 11.96B | |
-14.95% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B |
- Stock Market
- Equities
- 1061 Stock
- News Essex Bio-Technology Limited
- Tranche Update on Essex Bio-Technology Limited's Equity Buyback Plan announced on May 12, 2022.